InactivatingKISS1Mutation and Hypogonadotropic Hypogonadism
Author(s) -
A. Kemal Topaloğlu,
Javier A. Tello,
Leman Damla Kotan,
Mehmet Nuri Özbek,
Mehmet Bertan Yılmaz,
Şeref Erdoğan,
Fatih Gürbüz,
Fatih Temiz,
Robert P. Millar,
Bilgin Yüksel
Publication year - 2012
Publication title -
new england journal of medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 19.889
H-Index - 1030
eISSN - 1533-4406
pISSN - 0028-4793
DOI - 10.1056/nejmoa1111184
Subject(s) - kisspeptin , hypogonadotropic hypogonadism , neurokinin b , endocrinology , medicine , regulator , gonadotropin releasing hormone , mutation , hypothalamus , receptor , biology , hormone , gene , neuropeptide , genetics , luteinizing hormone , substance p
Gonadotropin-releasing hormone (GnRH) is the central regulator of gonadotropins, which stimulate gonadal function. Hypothalamic neurons that produce kisspeptin and neurokinin B stimulate GnRH release. Inactivating mutations in the genes encoding the human kisspeptin receptor (KISS1R, formerly called GPR54), neurokinin B (TAC3), and the neurokinin B receptor (TACR3) result in pubertal failure. However, human kisspeptin loss-of-function mutations have not been described, and contradictory findings have been reported in Kiss1-knockout mice. We describe an inactivating mutation in KISS1 in a large consanguineous family that results in failure of pubertal progression, indicating that functional kisspeptin is important for puberty and reproduction in humans. (Funded by the Scientific and Technological Research Council of Turkey [TÜBİTAK] and others.).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom